Results 221 to 230 of about 71,608 (348)
Can Preventative Antiepileptic Therapy Alter Outcome in Infants with Tuberous Sclerosis Complex? [PDF]
Carl E. Stafstrom, Gregory L. Holmes
openalex +1 more source
PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment
The PI3K/AKT/mTOR signaling axis is crucial in cancer progression, regulating cell growth, survival, and metabolism. Often hyperactivated through mutations or loss of tumor suppressors such as PTEN, this pathway promotes cancer cell proliferation and survival by inhibiting apoptosis and activating mTOR, which drives protein synthesis and suppresses ...
Mingyang Jiang+10 more
wiley +1 more source
A 24-year-Old woman with recurrent pneumothoraces
Lymphangioleiomyomatosis (LAM) is an abnormal proliferation of smooth muscle-like cells and may occur sporadically or in association with tuberous sclerosis complex.
Daniel J. Greenberg+3 more
doaj
Blood Biomarkers to Identify Renal Angiomyolipomas in People With Tuberous Sclerosis Complex. [PDF]
Balthazard R+12 more
europepmc +1 more source
Massive hepatic angiomyolipoma in a young woman with tuberous sclerosis complex: Significant clinical improvement during tamoxifen treatment [PDF]
Ilaria Lenci+7 more
openalex +1 more source
Why does infantile epileptic spasms syndrome (IESS) occur with a variety of underlying conditions and why does it respond to adrenocorticotrophin hormone (ACTH)/corticosteroids? Our scoping review summarizes five hypotheses from the literature: gene/epigenetic regulation, stress/HPA axis activation, neuroinflammation/immune function, altered neuronal ...
Emily A. Innes+6 more
wiley +1 more source
New insights into tuberous sclerosis complex: from structure to pathogenesis. [PDF]
Chen CS, Aylett CHS.
europepmc +1 more source
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis [PDF]
John J. Bissler+11 more
openalex +1 more source